Larvol Delta - Altimmune-Announces-Completion-of-Dosing-in-the-Phase-2-MOMENTUM-Trial-of-Pemvidutide-in-Subjects-with-Obesity-or-Overweight

pemvidutide (ALT-801) - Altimmune

https://www.globenewswire.com/news-release/2023/09/12/2741525/0/en/Altimmune-Announces-Completion-of-Dosing-in-the-Phase-2-MOMENTUM-Trial-of-Pemvidutide-in-Subjects-with-Obesity-or-Overweight.html

Sep 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next